SG/CALL/STRYKER CORP./300/0.1/21.06.24 Share Price

Warrant

DE000SQ4VR52

Delayed Deutsche Boerse AG 07:17:51 03/06/2024 pm IST
3.78 EUR +2.72% Intraday chart for SG/CALL/STRYKER CORP./300/0.1/21.06.24
1 month-5.15%
3 months-29.90%
Date Price Change
03/24/03 3.78 +2.72%
31/24/31 3.68 -4.17%
30/24/30 3.84 -1.29%
29/24/29 3.89 +8.06%
28/24/28 3.6 +22.87%

Delayed Quote Deutsche Boerse AG

Last update June 03, 2024 at 07:17 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SQ4VR5
ISINDE000SQ4VR52
Date issued 25/11/2022
Strike 300 $
Maturity 21/06/2024 (18 Days)
Parity 10 : 1
Emission price 1.68
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 6.01
Lowest since issue 1.02
Delta0x
Omega 0.000000
Premium0x
Gearing0x
Moneyness 1.133
Difference Strike -39.15 $
Difference Strike %-13.05%
Intrinsic value 3.719

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.1 USD
Average target price
373.1 USD
Spread / Average Target
+9.38%
Consensus